Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use

Influenza A viruses (IAV) spread rapidly and can infect a broad range of avian or mammalian species, having a tremendous impact in human and animal health and the global economy. IAV have evolved to develop efficient mechanisms to counteract innate immune responses, the first host mechanism that res...

Full description

Bibliographic Details
Main Authors:	Aitor Nogales, Marta L. DeDiego, Luis Martínez-Sobrido
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	influenza A virus non-structural 1 (NS1) protein live-attenuated influenza vaccine (LAIV) differentiating infected from vaccinated animals (DIVA) interferon
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.954811/full

Similar Items

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
by: Kenneth Sik-Kwan Chan, et al.
Published: (2022-09-01)

Protection of children against influenza: Emerging problems
by: Nicola Principi, et al.
Published: (2018-03-01)

Immune responses after live attenuated influenza vaccination
by: Kristin G.-I. Mohn, et al.
Published: (2018-03-01)

The applications of live attenuated influenza a virus with modified NS1 gene
by: Hongbo Zhang, et al.
Published: (2025-03-01)

Safety, Immunogenicity, and Protective Efficacy of a Chimeric A/B Live Attenuated Influenza Vaccine in a Mouse Model
by: Ekaterina Stepanova, et al.
Published: (2021-01-01)

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
by: Chantelle L. White, et al.
Published: (2021-06-01)

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein
by: Polina Prokopenko, et al.
Published: (2023-02-01)

Mutation E48K in PB1 Polymerase Subunit Improves Stability of a Candidate Live Attenuated Influenza B Virus Vaccine
by: Jongsuk Mo, et al.
Published: (2021-07-01)

Quadrivalent Live-Attenuated Influenza Vaccine in Milan preschools: an Italian experience of school-located flu vaccination within the 2022–2023 season
by: Stefania Roncaglia, et al.
Published: (2024-05-01)

Truncated NS1 Influenza A Virus Induces a Robust Antigen-Specific Tissue-Resident T-Cell Response and Promotes Inducible Bronchus-Associated Lymphoid Tissue Formation in Mice
by: Anna-Polina Shurygina, et al.
Published: (2025-01-01)

Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
by: Thomas A. Hilimire, et al.
Published: (2020-01-01)

Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses
by: Sujuan Chen, et al.
Published: (2017-06-01)

Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site
by: Tatiana Kotomina, et al.
Published: (2018-12-01)

Live attenuated influenza A virus vaccine expressing an IgA-inducing protein protects pigs against replication and transmission
by: Daniela S. Rajao, et al.
Published: (2023-02-01)

Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine
by: Aitor Nogales, et al.
Published: (2022-06-01)

A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity
by: Andrew Cox, et al.
Published: (2020-10-01)

A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus
by: Pilar Blanco-Lobo, et al.
Published: (2019-10-01)

Increased adherence to influenza vaccination among Palermo family pediatricians: a study on safety and compliance of qLAIV vaccination
by: Claudio Costantino, et al.
Published: (2024-07-01)

The influence of seasonal influenza viruses biological features on the effectiveness of development strains for live influenza vaccine
by: N. V. Larionova, et al.
Published: (2019-11-01)

Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
by: Dominic Thorrington, et al.
Published: (2017-09-01)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01)

The new temperature-sensitive mutation PA-F35S for developing recombinant avian live attenuated H5N1 influenza vaccine
by: Zhang Wenting, et al.
Published: (2012-05-01)

Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
by: Aitor Nogales, et al.
Published: (2021-04-01)

Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis
by: Constantina Boikos, et al.
Published: (2017-06-01)

Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA
by: Philip S. Gould, et al.
Published: (2017-09-01)

Natural Selection of H5N1 Avian Influenza A Viruses with Increased PA-X and NS1 Shutoff Activity
by: Aitor Nogales, et al.
Published: (2021-09-01)

Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
by: Yo Han Jang, et al.
Published: (2021-04-01)

Influenza Virus and Vaccination
by: Aitor Nogales, et al.
Published: (2020-03-01)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
by: Giulia Perego, et al.
Published: (2021-09-01)

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes
by: Tatiana Kotomina, et al.
Published: (2020-11-01)

T and B Cell Immune Responses to Influenza Viruses in Pigs
by: Barbara Holzer, et al.
Published: (2019-02-01)

Optimized properties of live vaccine influenza reassortant strains obtained by reverse genetics
by: N. V. Larionova, et al.
Published: (2023-12-01)

Applying conserved peptides of NS1 Protein of avian influenza virus to differentiate infected from vaccinated chickens
by: Golchinfar, F.,, et al.
Published: (2014-05-01)

Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
by: Yu. A. Desheva, et al.
Published: (2016-02-01)

Identification of Amino Acid Residues Responsible for Inhibition of Host Gene Expression by Influenza A H9N2 NS1 Targeting of CPSF30
by: Laura Rodriguez, et al.
Published: (2018-10-01)

An Optimised Live Attenuated Influenza Vaccine Ferret Efficacy Model Successfully Translates H1N1 Clinical Data
by: Katarzyna E. Schewe, et al.
Published: (2024-11-01)

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study
by: Li Li, et al.
Published: (2022-10-01)

Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections
by: D. Korenkov, et al.
Published: (2018-04-01)

The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary
by: Romain Paillot, et al.
Published: (2016-06-01)

Influenza Virus Carrying a Codon-Reprogrammed Neuraminidase Gene as a Strategy for Live Attenuated Vaccine
by: Ji Dong, et al.
Published: (2023-02-01)